SMT opens Asia’s largest stent manufacturing facility in Hyderabad

Once it becomes fully operational, its Hyderabad facility will produce 1.2 million stents  and two million catheters per year. 

Published: 16th April 2022 03:41 AM  |   Last Updated: 16th April 2022 03:41 AM   |  A+A-


​(Representational Image)

By Express News Service

HYDERABAD: In a major boost to medical devices manufacturing and med-tech innovations in the State, Sahajanand Medical Technologies (SMT) has opened Asia’s largest stent manufacturing facility at Medical Devices Park on Friday

IT and Industries Minister KT Rama Rao officially inaugurated the first phase of SMT Global Hub for Manufacturing and R&D of minimally invasive cardiovascular devices at the Medical Devices 

The facility, which will comprise cardiac stent manufacturing unit and an R&D centre, will be spread over 20 acres and a total of two lakh sqft space will be created in the first phase.SMT is a global leader in manufacturing cardiovascular devices. Once it becomes fully operational, its Hyderabad facility will produce 1.2 million stents and two million catheters per year. 

The facility will also boast minimally invasive new age and highly advanced cardiac products like Transcatheter Aortic Valve Implantation (TAVI) and Heart Occluders used in patients ranging from the elderly population to paediatrics.

The SMT R&D centre will focus on developing advanced medical products in interventional, structural and endovascular products in the niche domain of cardiology. The manufacturing unit will be instrumental in generating employment opportunities for close to 2,000 people in the State. 

In addition to this, the global R&D centre will employ over 300 highly qualified scientists. The facility will give a significant boost to ‘Make in India’ stent manufacturing and reducing India’s dependency on foreign stents, which are imported with heavy duties.

Speaking on the occasion, Minister Rama Rao said that over the years Telangana has recognised the medical device segment as a high-potential and high-growth sector, which presents unlimited opportunities and a preferred destination for investment and expansion.

“Today’s inauguration of SMT’s state-of-the-art stent manufacturing and cardiac devices facility is a step towards making available high quality, indigenously made, affordable healthcare products that will be made in Telangana for a global populace,” he said.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp